Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:ISRG News 7 January 2026 - 22 January 2026

Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical reported Q4 revenue up 19% to $2.87 billion and adjusted earnings of $2.53 per share, beating analyst estimates. Shares rose about 3% in after-hours trading. The company forecast 13% to 15% growth in da Vinci procedures for 2026, slower than 2025, and warned tariffs may pressure margins. Intuitive installed 532 da Vinci systems in the quarter, ending 2025 with 11,106 in use.
22 January 2026
·····
Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical shares rose 0.9% to $528.38 Thursday ahead of fourth-quarter earnings, after a recent slide left the stock 14% below its 52-week high. Investors are focused on growth in da Vinci procedures for 2026 after last week’s cautious outlook. The company reported preliminary Q4 revenue of $2.87 billion, up 19% year over year. Results and management commentary are due after the bell.
22 January 2026
·····
Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical shares fell 1.5% to $526.76 Tuesday afternoon, mirroring broader U.S. market declines. The company is set to report earnings Jan. 22 after signaling da Vinci procedure growth of 13%–15% in 2026 and preliminary Q4 revenue near $2.87 billion. Investors remain focused on procedure outlook and competition from Medtronic and Johnson & Johnson.
20 January 2026
·····
Why Intuitive Surgical stock price is in focus: ISRG heads into earnings week after Friday dip

Why Intuitive Surgical stock price is in focus: ISRG heads into earnings week after Friday dip

Intuitive Surgical closed down 1.2% at $535 on Friday after forecasting 2026 da Vinci procedure growth of 13%–15%, below analyst expectations. Preliminary Q4 revenue was $2.87 billion, up 19% year over year, with 532 da Vinci systems placed. U.S. markets will reopen Tuesday after the Martin Luther King Jr. Day holiday. Shares may react further after the company’s Jan. 22 results.
19 January 2026
····
Intuitive Surgical stock (ISRG) heads into earnings week after Friday drop — what to watch next

Intuitive Surgical stock (ISRG) heads into earnings week after Friday drop — what to watch next

Intuitive Surgical shares fell 1.2% to $535 on Friday, marking five straight sessions of losses as trading volume rose. The company reported preliminary Q4 revenue of $2.87 billion, up 19% year-over-year, and a 17% increase in da Vinci procedures. CEO Dave Rosa said da Vinci 5 usage is 11% higher than the Xi model. Full Q4 results are due Jan. 22.
17 January 2026
·····
Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings

Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings

Intuitive Surgical shares fell 0.9% to $536.49 in early New York trading Friday after the company’s 2026 da Vinci procedure-growth forecast missed some investor expectations. The company reported unaudited Q4 revenue of $2.87 billion, up 19%, and projected 2026 da Vinci procedure growth of 13% to 15%. Investors await more detail at the Jan. 22 earnings call.
16 January 2026
·····
Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

New York, January 15, 2026, 12:06 (EST) — Regular session Intuitive Surgical shares dropped once more on Thursday, continuing a selloff sparked by the company’s weaker growth forecast for procedures involving its da Vinci surgical robot. The stock slipped roughly 1% to $541.08 in midday trading, following a 2.7% drop on Wednesday. The procedure forecast is crucial because every da Vinci surgery drives repeat sales — the single-use instruments and accessories hospitals need for each operation. If that volume dips, the growth story shrinks, even if robot deliveries remain steady. Investors are weighing how quickly Intuitive can roll out its
15 January 2026
·····
Intuitive Surgical (ISRG) stock drops after 2026 da Vinci outlook flags slower growth

Intuitive Surgical (ISRG) stock drops after 2026 da Vinci outlook flags slower growth

New York, Jan 14, 2026, 17:40 (EST) — After-hours Shares of Intuitive Surgical dropped 2.7% to close at $546.76 on Wednesday, after the company projected slower growth in da Vinci procedures for 2026.Intuitive now expects procedure growth to hit roughly 13% to 15%. CEO Dave Rosa said they were “pleased with our strong performance” following a preliminary Q4 revenue report of $2.87 billion. (archive.fast-edgar.com) This procedure range is crucial because it offers the clearest glimpse investors have into demand for surgical robotics. Growth in procedures fuels the ongoing revenue streams — from instruments and accessories to service — rather than
15 January 2026
·····
Intuitive Surgical stock: Bernstein lifts ISRG target as JPM conference week begins

Intuitive Surgical stock: Bernstein lifts ISRG target as JPM conference week begins

New York, Jan 11, 2026, 16:22 EST — Market closed. Bernstein bumped up its price target on Intuitive Surgical (ISRG.O) to $740 from $700, maintaining an “Outperform” rating. The robotic surgery firm’s shares closed Friday up 0.2% at $586.24, after trading between $579.62 and $589.58. Its 52-week range stands at $425 to $616. (GuruFocus) U.S. markets are closed Sunday, yet the schedule keeps moving. J.P. Morgan’s annual Healthcare Conference takes place Jan. 12–15 in San Francisco. Intuitive is set to present at 9:00 a.m. PT on Wednesday. After that event, the next earnings report is expected around Jan. 22, according
11 January 2026
·······
Why Intuitive Surgical stock (ISRG) is back in focus after Bernstein lifts its target

Why Intuitive Surgical stock (ISRG) is back in focus after Bernstein lifts its target

New York, Jan 10, 2026, 16:37 EST — The market is closed. On Friday, Bernstein lifted its price target for Intuitive Surgical from $700 to $740, maintaining an Outperform rating. The move signals strong confidence as healthcare investors brace for a hectic period. (TipRanks) Intuitive Surgical shares ended Friday up 0.2%, closing at $586.24. During the day, the stock fluctuated between $579.62 and $589.58. Its 52-week range stands at $425 to $616, per Stock Analysis. (StockAnalysis) Why it matters now: investors are focused on the J.P. Morgan Healthcare Conference, set for Jan. 12-15 in San Francisco, while also waiting on
10 January 2026
·····
Intuitive Surgical stock steadies after-hours as Barclays lifts target; da Vinci 5 bets build

Intuitive Surgical stock steadies after-hours as Barclays lifts target; da Vinci 5 bets build

New York, Jan 7, 2026, 20:13 ET — After-hours Intuitive Surgical (ISRG.O) shares eased about 0.1% in after-hours trading on Wednesday to $592.27, after Barclays raised its price target on the robotic-surgery leader to $686 from $635 and kept an “Overweight” rating. The stock traded between $590 and $603.75 during the regular session. TipRanks The calls land as ISRG flirts with its recent highs and investors keep trying to pin down the next leg of growth: how quickly hospitals upgrade to the company’s newest da Vinci systems, and what that means for recurring sales. For Intuitive, the hardware sale is
8 January 2026
·····
Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings

Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings

New York, January 7, 2026, 04:55 ET — Premarket Intuitive Surgical, Inc. (ISRG.O) shares rose 4.6% to close at $592.85 on Tuesday and were last up about 0.4% in after-hours trading. MarketWatch The move matters now because January is a key checkpoint for medical device stocks, with investors looking for early-year signals on hospital spending and procedure demand. For Intuitive, even small changes in tone around system placements and recurring instrument sales can quickly shift expectations. The stock is near the top of its 52-week range and carries a rich valuation, which can amplify swings around news. Nasdaq data show
7 January 2026
·····
1 2 3 4

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop